Literature DB >> 20309013

Langerin functions as an antiviral receptor on Langerhans cells.

Michiel van der Vlist1, Teunis B H Geijtenbeek.   

Abstract

Langerhans cells (LC) are the first dendritic cells (DC) to encounter pathogens entering the body via mucosa or skin. Equipped with pattern recognition receptors (PRR), LC are able to detect and respond to these pathogens. An important PRR, in human exclusively expressed by LC, is the C-type lectin Langerin. Langerin forms a protective barrier against HIV-1 infection by binding and degradation of this virus. In addition, antigens targeted to Langerin are presented to T cells to induce an adaptive immune response. Therefore Langerin functions as an innate anti-viral defense mechanism and an antigen receptor involved in adaptive immune responses. Here, we review the role of Langerin in antiviral protection, its structural similarity to other C-type lectins, and how its function and polymorphisms influence the function of Langerhans cells.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20309013     DOI: 10.1038/icb.2010.32

Source DB:  PubMed          Journal:  Immunol Cell Biol        ISSN: 0818-9641            Impact factor:   5.126


  30 in total

1.  The Langerhans cell controversy: are they immunostimulatory or immunoregulatory cells of the skin immune system?

Authors:  Patrizia Stoitzner
Journal:  Immunol Cell Biol       Date:  2010 May-Jun       Impact factor: 5.126

Review 2.  Novel Insights Into the Immunoregulatory Function and Localization of Dendritic Cells.

Authors:  Takaaki Hattori; Hiroki Takahashi; Reza Dana
Journal:  Cornea       Date:  2016-11       Impact factor: 2.651

3.  A new cellular target for Yersinia pestis.

Authors:  Juan J Garcia-Vallejo; Yvette van Kooyk
Journal:  Immunol Cell Biol       Date:  2015-06-30       Impact factor: 5.126

4.  Lipid Nanoparticle Assisted mRNA Delivery for Potent Cancer Immunotherapy.

Authors:  Matthias A Oberli; Andreas M Reichmuth; J Robert Dorkin; Michael J Mitchell; Owen S Fenton; Ana Jaklenec; Daniel G Anderson; Robert Langer; Daniel Blankschtein
Journal:  Nano Lett       Date:  2016-12-05       Impact factor: 11.189

5.  New insights into the molecular pathogenesis of langerhans cell histiocytosis.

Authors:  Francesca M Rizzo; Mauro Cives; Valeria Simone; Franco Silvestris
Journal:  Oncologist       Date:  2014-01-16

6.  The C-type Lectin Langerin Functions as a Receptor for Attachment and Infectious Entry of Influenza A Virus.

Authors:  Wy Ching Ng; Sarah L Londrigan; Najla Nasr; Anthony L Cunningham; Stuart Turville; Andrew G Brooks; Patrick C Reading
Journal:  J Virol       Date:  2015-10-14       Impact factor: 5.103

7.  Inhibition of predation by Bdellovibrio bacteriovorus and Micavibrio aeruginosavorus via host cell metabolic activity in the presence of carbohydrates.

Authors:  Aliza Dashiff; Thomas G Keeling; Daniel E Kadouri
Journal:  Appl Environ Microbiol       Date:  2011-02-11       Impact factor: 4.792

8.  HIV-1 replication in Langerhans and interstitial dendritic cells is inhibited by neutralizing and Fc-mediated inhibitory antibodies.

Authors:  M Peressin; V Holl; S Schmidt; T Decoville; D Mirisky; A Lederle; M Delaporte; K Xu; A M Aubertin; C Moog
Journal:  J Virol       Date:  2010-11-17       Impact factor: 5.103

9.  Exploitation of Langerhans cells for in vivo DNA vaccine delivery into the lymph nodes.

Authors:  E R Tőke; O Lőrincz; Z Csiszovszki; E Somogyi; G Felföldi; L Molnár; R Szipőcs; A Kolonics; B Malissen; F Lori; J Trocio; N Bakare; F Horkay; N Romani; C H Tripp; P Stoitzner; J Lisziewicz
Journal:  Gene Ther       Date:  2014-04-03       Impact factor: 5.250

10.  Antigen-presenting cell candidates for HIV-1 transmission in human distal colonic mucosa defined by CD207 dendritic cells and CD209 macrophages.

Authors:  Gloria C Preza; Karen Tanner; Julie Elliott; Otto O Yang; Peter A Anton; Maria-Teresa Ochoa
Journal:  AIDS Res Hum Retroviruses       Date:  2013-12-10       Impact factor: 2.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.